Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

G. E. Cooksley, W.; Piratvisuth, Teerha; Lee, Shin‐Da; Mahachai, Varocha; Chao, Y.‐C.; Tanwandee, Tawesak; Chutaputti, Anuchit; Y Chang, W; Zahm, Friederike; Pluck, N.

doi:10.1046/j.1365-2893.2003.00450.x

Public

Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

Published in Journal of Viral Hepatitis • Jun 23, 2003

Authors:

W. G. E. Cooksley

Teerha Piratvisuth

Shin‐Da Lee

Abstract

Current therapies for chronic hepatitis B (CHB) have a number of limitations, and better treatment options are needed. Peginterferon alpha-2a (40 kDa) is superior to conventional interferon alpha-2a in the treatment of chronic hepatitis C. This is the first report on peginterferon alpha-2a (40 kDa) ...

Subject

Medicine

HBeAg

Alpha interferon

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!